Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases

Isabel M. Ramírez, Nicolás Mendoza, Laura Baquedano, Sonia Sanchez, María Fasero, Borja Otero, Ester de la Viuda, Joaquin Calaf, Pluvio Coronado, Silvia González, Jesús Presa, Francisco Quereda, Ana Rosa Jurado, Verónica Nieto, Antonio Carballo, Mª. Angeles Leal, María Pancorbo, Placido Llaneza, Rafael Sánchez-Borrego, Amparo Santamaría, Javier Rodríguez Martorell, Gerard Espinosa, Dolores Vilas Rolan, Francisco Carmona, Josep Perelló, Ana Cris Lou, María López Lasanta, Silvia Oizerovich, Teresa Bombas, Patricio Barriga, Camil Castelo Branco, Peter Chedraui, Rossella E. Nappi, Santiago Palacios, Tommaso Simoncini, Angelica Lindén Hirschberg, Irene Lambrinoudaki

Open source

DOI: 10.1016/j.maturitas.2025.108208
Published: 2025-04
Container: Maturitas
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.maturitas.2025.108208,
  title = {Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases},
  author = {Isabel M. Ramírez and Nicolás Mendoza and Laura Baquedano and Sonia Sanchez and María Fasero and Borja Otero and Ester de la Viuda and Joaquin Calaf and Pluvio Coronado and Silvia González and Jesús Presa and Francisco Quereda and Ana Rosa Jurado and Verónica Nieto and Antonio Carballo and Mª. Angeles Leal and María Pancorbo and Placido Llaneza and Rafael Sánchez-Borrego and Amparo Santamaría and Javier Rodríguez Martorell and Gerard Espinosa and Dolores Vilas Rolan and Francisco Carmona and Josep Perelló and Ana Cris Lou and María López Lasanta and Silvia Oizerovich and Teresa Bombas and Patricio Barriga and Camil Castelo Branco and Peter Chedraui and Rossella E. Nappi and Santiago Palacios and Tommaso Simoncini and Angelica Lindén Hirschberg and Irene Lambrinoudaki},
  year = {2025},
  journal = {Maturitas},
  doi = {10.1016/j.maturitas.2025.108208},
  url = {https://doi.org/10.1016/j.maturitas.2025.108208}
}

RIS

TY  - JOUR
TI  - Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases
AU  - Isabel M. Ramírez
AU  - Nicolás Mendoza
AU  - Laura Baquedano
AU  - Sonia Sanchez
AU  - María Fasero
AU  - Borja Otero
AU  - Ester de la Viuda
AU  - Joaquin Calaf
AU  - Pluvio Coronado
AU  - Silvia González
AU  - Jesús Presa
AU  - Francisco Quereda
AU  - Ana Rosa Jurado
AU  - Verónica Nieto
AU  - Antonio Carballo
AU  - Mª. Angeles Leal
AU  - María Pancorbo
AU  - Placido Llaneza
AU  - Rafael Sánchez-Borrego
AU  - Amparo Santamaría
AU  - Javier Rodríguez Martorell
AU  - Gerard Espinosa
AU  - Dolores Vilas Rolan
AU  - Francisco Carmona
AU  - Josep Perelló
AU  - Ana Cris Lou
AU  - María López Lasanta
AU  - Silvia Oizerovich
AU  - Teresa Bombas
AU  - Patricio Barriga
AU  - Camil Castelo Branco
AU  - Peter Chedraui
AU  - Rossella E. Nappi
AU  - Santiago Palacios
AU  - Tommaso Simoncini
AU  - Angelica Lindén Hirschberg
AU  - Irene Lambrinoudaki
PY  - 2025
JO  - Maturitas
DO  - 10.1016/j.maturitas.2025.108208
UR  - https://doi.org/10.1016/j.maturitas.2025.108208
ER  -

APA

Ramírez, I. M., Mendoza, N., Baquedano, L., Sanchez, S., Fasero, M., Otero, B., Viuda, E. D. L., Calaf, J., Coronado, P., González, S., Presa, J., Quereda, F., Jurado, A. R., Nieto, V., Carballo, A., Leal, M. A., Pancorbo, M., Llaneza, P., Sánchez-Borrego, R., Santamaría, A., Martorell, J. R., Espinosa, G., Rolan, D. V., Carmona, F., Perelló, J., Lou, A. C., Lasanta, M. L., Oizerovich, S., Bombas, T., Barriga, P., Branco, C. C., Chedraui, P., Nappi, R. E., Palacios, S., Simoncini, T., Hirschberg, A. L., & Lambrinoudaki, I. (2025). Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases. Maturitas. https://doi.org/10.1016/j.maturitas.2025.108208

Source records

crossref · retrieved 2026-09-27T03:38:53.991Z